RxDoctor Payments Data

Mike Bevers

Physician Assistant · Rehoboth Beach, DENPI 1508899485

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.5% of the total across 277 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,597 and has fallen 95.4% since, to $74 in 2025. Among physician assistant clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,176in general payments, 2019–2025

Across 277 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$877
  • Johnson & Johnson$794
  • UCB, Inc.$754
  • Sanofi$573
  • Novartis$401
  • Lilly USA, LLC$380
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$5,09698%
  • Education$802%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,176 in reported general payments places this provider in the 95th percentile of 527 physician assistant providers in Delaware.

See all physician assistant providers in Delaware

Medicare billing

Part B allowed, 2024
$92,378
Medicare patients
635
Services billed
2,024

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab51$186,124
Clobetasol Propionate112$5,352
Fluorouracil18$1,790
Triamcinolone Acetonide128$1,532
Doxycycline Hyclate85$1,513
Ketoconazole88$1,381
Mometasone Furoate59$1,317
Hydrocortisone101$1,228
Fluocinolone AcetonideFluocinolone/Shower Cap18$778
CefuroximeCefuroxime Axetil28$756
Metronidazole11$725
Clindamycin Phosphate18$500
Doxycycline Monohydrate19$438
Cyproheptadine Hcl13$338
Minocycline Hcl16$247

Paid to pharmacies, not to this prescriber.

Other physician assistant in Rehoboth Beach

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →